News #Gene therapy


C2C on Lancet Haematology

C2C on Lancet Haematology

C2C contributed to an article on Sickle Cell Disease treatment in the prestigious medical journal Lancet Haematology.

Read More  
Breakthrough for thalassemia and sickle cell disease presented at the 2020 meeting of the American Society of Hematology

Breakthrough for thalassemia and sickle cell disease presented at the 2020 meeting of the American Society of Hematology

On Sunday December 6 2020, Dr. Haydar Frangoul from Tristar Children's Hospital, Nashville, TN, USA, presented preliminary results of gene editing for the cure of Thalassemia and sickle cell disease.

Read More